Theodore Nicolaides, MD

University of California San Francisco

Immunotherapy and targeted therapy in MAPK -activated pediatric gliomas

At University of California San Francisco, Dr. Nicolaides is developing treatments for children with glioma brain tumors. A new drug shown to be successful against this tumor has also shown to be very susceptible to resistance in certain patients. Understanding how that resistance develops can result in more effective drugs, and ultimately save lives.

Awarded in 2017